Jeff Duan
Patrimonio netto: 55 M $ in data 30/09/2026
Patrimonio netto: 55 M $ in data 30/09/2026
Ji Feng Duan is currently the Chief Executive Officer & Managing Director at PharmaLegacy Laboratories (Shanghai) Co., Ltd. since 2008.
Dr. Duan is also the Director at Shanghai OPM Biosciences Co. Ltd. starting in 2026.
The education history includes graduate studies at Tianjin Medical University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/08/2026 | 4.619.838 ( 18,46% ) | 55 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SHANGHAI OPM BIOSCIENCES CO., LTD. | Direttore/Membro del Consiglio | 27/02/2026 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Amministratore Delegato | 07/03/2008 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Tianjin Medical University
Tianjin Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai OPM Biosciences Co. Ltd.
Shanghai OPM Biosciences Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces animal cell serum-free media for optimization and antibody drug identification and analysis | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale